What is the best course of treatment for a 30-year-old male with dengue fever, presenting with danger signs and blurred vision?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Dengue with Danger Signs and Blurred Vision

This 30-year-old male requires immediate hospitalization with aggressive fluid resuscitation for dengue shock syndrome while simultaneously obtaining urgent ophthalmology consultation for vision-threatening dengue maculopathy. 1, 2

Immediate Resuscitation Protocol

Administer 20 mL/kg of isotonic crystalloid (Ringer's lactate or 0.9% normal saline) as a rapid bolus over 5-10 minutes with immediate reassessment after each bolus. 1, 2 The presence of "danger signs" indicates this patient is at high risk for progression to dengue shock syndrome, which has a mortality rate of 1-5% without proper management but can be reduced to <0.5% with appropriate clinical care. 2

Fluid Resuscitation Strategy

  • If shock persists after the initial bolus, repeat crystalloid boluses up to a total of 40-60 mL/kg in the first hour before escalating therapy. 1, 2
  • For severe shock with pulse pressure <10 mmHg, consider colloid solutions (gelafundin or albumin), as moderate-quality evidence shows colloids achieve faster resolution of shock (RR 1.09,95% CI 1.00-1.19) and reduce total volume needed (mean 31.7 mL/kg versus 40.63 mL/kg for crystalloids). 1
  • Monitor for signs of adequate resuscitation: improvement in tachycardia and tachypnea, normal capillary refill time, warm and dry extremities, well-felt peripheral pulses, return to baseline mental status, and adequate urine output (>0.5 mL/kg/hour). 1

Critical Monitoring Parameters

  • Obtain daily complete blood count to track platelet counts and hematocrit levels, as rising hematocrit indicates ongoing plasma leakage and need for continued resuscitation. 1, 3
  • Watch for warning signs of fluid overload: hepatomegaly, pulmonary rales, or respiratory distress—if these develop, stop fluid resuscitation immediately and switch to inotropic support. 1, 2
  • Monitor continuously with cardiac telemetry and pulse oximetry. 3

Management of Refractory Shock

If shock persists despite 40-60 mL/kg of crystalloid in the first hour, switch from aggressive fluid administration to inotropic support rather than continuing fluid boluses. 1

  • For cold shock with hypotension: titrate epinephrine as first-line vasopressor. 1
  • For warm shock with hypotension: titrate norepinephrine as first-line vasopressor. 1
  • Target mean arterial pressure appropriate for age and maintain ScvO2 >70%. 1

Management of Blurred Vision

Obtain urgent ophthalmology consultation for comprehensive fundoscopic examination to evaluate for dengue maculopathy, which can cause permanent visual impairment if not promptly recognized. 4, 5

Ocular Complications to Screen For

  • Dengue maculopathy presents with dilated veins, hyperemic optic discs, flame and blot hemorrhages, soft exudates, and macular ischemia. 4
  • Other vision-threatening complications include central retinal vein occlusion, acute macular neuroretinopathy, retinal vasculitis, and macular edema. 5, 6, 7
  • The pathophysiology involves both bleeding tendency from thrombocytopenia and procoagulant state from immune reaction, creating risk for both hemorrhagic and thrombotic events. 6

Treatment of Dengue Maculopathy

High-dose corticosteroids may improve visual acuity and color vision in dengue maculopathy, though there is no definitive proven treatment. 4, 5 Despite lack of proven efficacy, corticosteroids have been used in vision-threatening dengue-related ocular complications. 5 Time for resolution ranges from 8 weeks to 4 months, with risk of residual visual impairment. 4

Supportive Care

  • Use acetaminophen (paracetamol) only for pain and fever management. 1, 3
  • Never use aspirin or NSAIDs under any circumstances due to high bleeding risk. 1, 2, 3
  • Blood transfusion may be necessary for significant bleeding, with target hemoglobin >10 g/dL if ScvO2 <70%. 1, 2

Critical Pitfalls to Avoid

  • Do not delay fluid resuscitation in established dengue shock syndrome, as cardiovascular collapse may rapidly follow once hypotension occurs. 1, 2
  • Do not continue aggressive fluid resuscitation once signs of fluid overload appear—switch to inotropic support instead. 1, 2
  • Do not give routine bolus IV fluids to patients with severe febrile illness who are not in shock, as this increases fluid overload and respiratory complications without improving outcomes. 1
  • Do not fail to recognize the critical phase (typically days 3-7 of illness) when plasma leakage can rapidly progress to shock. 1, 2
  • Do not overlook ocular complications—systematically screen for maculopathy when visual disturbances arise, as dengue fever should be suspected in travelers from endemic areas. 4, 5

Post-Resuscitation Management

After initial shock reversal, fluid removal may be necessary, as evidence shows aggressive shock management followed by judicious fluid removal decreased pediatric ICU mortality from 16.6% to 6.3%. 1, 2 Consider continuous renal replacement therapy (CRRT) if fluid overload >10% develops, as outcomes are better when CRRT is initiated early. 1

References

Guideline

Dengue Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Dengue Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Dengue Fever Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Dengue maculopathy: a case report.

Travel medicine and infectious disease, 2007

Research

An update on the ocular manifestations of dengue.

Taiwan journal of ophthalmology, 2024

Research

Central retinal vein occlusion concomitant with dengue fever.

International journal of retina and vitreous, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.